--- title: "HealthStream | 8-K: FY2025 Q4 Revenue Beats Estimate at USD 79.71 M" type: "News" locale: "zh-CN" url: "https://longbridge.com/zh-CN/news/276647951.md" datetime: "2026-02-23T21:37:41.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/276647951.md) - [en](https://longbridge.com/en/news/276647951.md) - [zh-HK](https://longbridge.com/zh-HK/news/276647951.md) --- > 支持的语言: [English](https://longbridge.com/en/news/276647951.md) | [繁體中文](https://longbridge.com/zh-HK/news/276647951.md) # HealthStream | 8-K: FY2025 Q4 Revenue Beats Estimate at USD 79.71 M Revenue: As of FY2025 Q4, the actual value is USD 79.71 M, beating the estimate of USD 76.21 M. EPS: As of FY2025 Q4, the actual value is USD 0.09, missing the estimate of USD 0.11. EBIT: As of FY2025 Q4, the actual value is USD 1.765 M. #### Fourth Quarter 2025 Financial Highlights Operating income for the fourth quarter of 2025 was $2.4 million, representing a 48.8% decrease from $4.7 million in the prior year quarter, primarily due to a $3.8 million charge related to the CEO Stock Gift. Excluding this impact, non-GAAP operating income was $6.2 million, an increase of 31.7% from $4.7 million in the fourth quarter of 2024. Net income decreased by 48.1% to $2.5 million from $4.9 million in the fourth quarter of 2024, with a - $2.8 million negative impact from the CEO Stock Gift. Non-GAAP net income, excluding the CEO Stock Gift impact, was $5.4 million, an increase of 9.5% from $4.9 million in the prior year quarter. Adjusted EBITDA increased by 16.4% to $18.8 million from $16.2 million in the fourth quarter of 2024. As of December 31, 2025, HealthStream, Inc. held $57.0 million in cash and cash equivalents and marketable securities. Capital expenditures incurred during the fourth quarter of 2025 totaled $7.0 million. The company repurchased $5.0 million of outstanding shares in the fourth quarter as part of an authorized $10.0 million share repurchase program. #### Full-Year 2025 Financial Highlights For the full year 2025, operating income decreased by 4.9% to $20.2 million from $21.3 million in 2024, influenced by a - $3.8 million CEO Stock Gift charge. Non-GAAP operating income, excluding the CEO Stock Gift, increased by 12.8% to $24.0 million from $21.3 million in 2024. Net income for 2025 was $18.3 million, down 8.3% from $20.0 million in 2024. Non-GAAP net income, excluding the CEO Stock Gift, increased by 5.8% to $21.2 million from $20.0 million in 2024. Adjusted EBITDA for the full year increased by 7.5% to $71.8 million from $66.8 million in 2024. Capital expenditures incurred during 2025 totaled $31.9 million. The company repurchased 1,111,590 shares of common stock at an aggregate fair value of $30.0 million during the twelve months ended December 31, 2025. #### Cash Flow and Balance Sheet (Full-Year 2025) Net cash provided by operating activities for 2025 was $63,319 thousand, compared to $57,660 thousand in 2024. Net cash used in investing activities was - $50,353 thousand in 2025, up from - $33,972 thousand in 2024. Net cash used in financing activities was - $36,267 thousand in 2025, compared to - $4,516 thousand in 2024. Cash and cash equivalents at the end of 2025 were $36,161 thousand, down from $59,469 thousand at the end of 2024. Total assets were $520,374 thousand as of December 31, 2025, while total liabilities were $166,351 thousand and total shareholders’ equity was $354,023 thousand. #### 2026 Outlook 健康流科技 (HealthStream, Inc.) projects full-year 2026 net income to range from $20.4 million to $22.8 million and Adjusted EBITDA between $73.0 million and $77.0 million. Capital expenditures for 2026 are anticipated to be between $31.0 million and $34.0 million. The Board of Directors declared a quarterly cash dividend of $0.035 per share, an increase of 12.9% over the previous quarter’s dividend, payable on March 20, 2026, to holders of record on March 9, 2026. ### 相关股票 - [HealthStream (HSTM.US)](https://longbridge.com/zh-CN/quote/HSTM.US.md) ## 相关资讯与研究 - [Virsys12® Named a Leader in the IDC MarketScape: U.S. Provider Data Management for Payers 2025–2026 Vendor Assessment | HSTM Stock News](https://longbridge.com/zh-CN/news/280639754.md) - [Key facts: Bunge Increases Securitization to $2.0B; 8-K on Obligation](https://longbridge.com/zh-CN/news/281659964.md) - [Here's What to Expect From Aon's Next Earnings Report](https://longbridge.com/zh-CN/news/281504911.md) - [Firefly Aerospace's Marc Weiser resigns from board](https://longbridge.com/zh-CN/news/281662054.md) - [Hong Kong committed to helping mainland China’s health standards ‘go global’](https://longbridge.com/zh-CN/news/281626240.md)